Answers are grounded in this paper and cite their sources.
Consensus guidelines report dose-escalation strategies in rectal cancer, highlighting the role of precise tumor delineation in achieving complete response and organ preservation.
In recent years, the treatment paradigm for rectal cancer (RC) has increasingly shifted toward dose intensification strategies, aiming to enhance complete response (CR) rates [1,2]. Achieving CR is clinically meaningful, as it significantly increases the likelihood of organ preservation and functional sphincter-sparing outcomes—particularly critical in younger patients, for whom long-term quality of life (QoL) and avoidance of permanent colostomy are paramount [3,4] and older patients with comorbidities rendering them not suitable for surgery [5].
No takes yet. Share an insight, caveat, or question.
Chiloiro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: